Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lukas Bethlehem
Institution:
Icahn School of Medicine at Mount Sinai
Observed institutions:
University of Bonn,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0002-8039-2475
Observed ORCID:
0000-0002-8039-2475
OpenAlex ID:
A5003314931
Microbiota therapeutics for inflammatory bowel disease: the way forward
2024
·
Lukas Bethlehem
, Maria Manuela Estevinho
, et al.
·
The Lancet. Gastroenterology & hepatology
·
91
PDF
Ectoines as novel anti-inflammatory and tissue protective lead compounds with special focus on inflammatory bowel disease and lung inflammation
2020
·
Lukas Bethlehem
, Gerhild van Echten-Deckert
·
Pharmacological Research
·
41
Boosting Escherichia coli’s heterologous production rate of ectoines by exploiting the non-halophilic gene cluster from Acidiphilium cryptum
2020
·
Lukas Bethlehem
, Katharina D. Moritz
·
Extremophiles
·
19
PDF
15-strain live biotherapeutic product or same donor fecal microbiota transplant for recurrent Clostridioides difficile infection: a randomized phase 1b trial
2026
·
Lukas Bethlehem
, Lorenza Bartu
, et al.
·
Nature Medicine
·
7
Accessible Microbiota Drug Development: First Head-to-Head Trial of Defined LBP vs. FMT
2025
·
Lukas Bethlehem
Design & generation of an efficient E. coli cell-factory for the overproduction of the compatible solutes ectoine & hydroxyectoine
2020
·
Lukas Bethlehem
·
bonndoc (University of Bonn)
Show more works
View as search
Works count:
6
Citation count:
158
H-index:
4
I10-index:
3
Year
Topic
Type